These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11777766)

  • 1. Stabilization of the hydrophilic sphere of non-ionic monomers: are all protected in a similar way?
    Violon D
    Br J Radiol; 2001 Dec; 74(888):1097-102. PubMed ID: 11777766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of the hydrophilic sphere of iobitridol, a new nonionic iodinated contrast agent.
    Meyer D; Petta M; Fouchet MH; Vadel M; Schaefer M; Dugast-Zrihen M; Guillemot M
    Acta Radiol Suppl; 1996; 400():8-16. PubMed ID: 8619359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the factors influencing the osmolality of eight monomeric nonionic iodinated contrast medium molecules.
    Violon D
    Invest Radiol; 1997 Nov; 32(11):684-9. PubMed ID: 9387056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of the hydrophilic sphere of iobitridol.
    Carrupt PA; Testa B
    Br J Radiol; 2003 Feb; 76(902):147; author reply 147-8. PubMed ID: 12642287
    [No Abstract]   [Full Text] [Related]  

  • 5. Stabilization of the hydrophilic sphere of iobitridol, an iodinated contrast agent, as revealed by experimental and computational investigations.
    Meyer D; Fouchet MH; Petta M; Carrupt PA; Gaillard P; Testa B
    Pharm Res; 1995 Nov; 12(11):1583-91. PubMed ID: 8592654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the complex between the contrast agent Iobitridol (Xenetix) and Elastase (PPE): a model for hydrophobic site protection in drug-protein interactions.
    Prangé T; Neuman A; Corot C; Meyer D
    Pharm Res; 1997 Dec; 14(12):1713-7. PubMed ID: 9453058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the lateral/facial protection model to a new molecule, iobitridol.
    Violon D
    Invest Radiol; 1996 Oct; 31(10):668-70. PubMed ID: 8889656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium.
    Hutcheson IR; Griffith TM; Pitman MR; Towart R; Gregersen M; Refsum H; Karlsson JO
    Br J Pharmacol; 1999 Sep; 128(2):451-7. PubMed ID: 10510457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Iopromide, a new contrast medium for angiography. Clinical study and comparison with other low-osmolar contrast media].
    Steidle B; Wolf KJ; Banzer D; Seyferath W
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1275-8. PubMed ID: 6381018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the efficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency.
    Stacul F; Cova M; Assante M; Hougens Grynne B; Haider T
    Br J Radiol; 1998 Sep; 71(849):918-22. PubMed ID: 10195004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Balanced facial hydrophilicity of ioversol: a qualitative approach of hydrophilicity].
    Meyer D; Bonnemain B; Dugast-Zrihen M; Le Greneur S
    Ann Radiol (Paris); 1992; 35(4 Pt 2):263-6. PubMed ID: 1296488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viscosity of contrast media perturbs renal hemodynamics.
    Seeliger E; Flemming B; Wronski T; Ladwig M; Arakelyan K; Godes M; Möckel M; Persson PB
    J Am Soc Nephrol; 2007 Nov; 18(11):2912-20. PubMed ID: 17942967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoconstriction of isolated arteries induced by angiographic contrast media. A comparison of ionic and non-ionic contrast media iso-osmolar with plasma.
    Karstoft J; Bååth L; Jansen I; Edvinsson L
    Acta Radiol; 1995 May; 36(3):312-6. PubMed ID: 7742129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrocorticographic evaluation of the neurologic tolerability of iobitridol (Xenetix), a new non-ionic contrast medium in rabbits].
    Idée JM; Hartl C; Santus R; Doucet D; Bonnemain B
    J Radiol; 1995 Jul; 76(7):423-9. PubMed ID: 7473376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Double-blind randomized study comparing ioversol 300 versus iopromide 300 abdominal computed tomography (CT scanner)].
    Hoogewoud HM; Neiss AC; Woessmer B
    Ann Radiol (Paris); 1992; 35(4 Pt 2):273-5. PubMed ID: 1296490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of biodistribution and changes in density following administration of iobitridol in rabbits. A comparative study vs iohexol.
    Rouleau P; Alison D; Bertrand P; Benderbous S; Havard P; Chambon C
    Acta Radiol Suppl; 1996; 400():49-55. PubMed ID: 8619352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of hematocrit and iodine concentrations following intravenous bolus administration of ionic and nonionic monomeric and dimeric contrast media--an animal experimental study].
    Claussen CD; Duda SH; Weinmann HJ
    Rofo; 1988 Nov; 149(5):529-33. PubMed ID: 2848287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent development in non-ionic contrast media.
    Hagen B
    Ann Radiol (Paris); 1989; 32(1):38-9. PubMed ID: 2742324
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.